Literature DB >> 7742038

Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D.

P Zhong1, M Peeters, W Janssens, K Fransen, L Heyndrickx, G Vanham, B Willems, P Piot, G van der Groen.   

Abstract

The relationship between the genetic variability in the V3 loop and the biological characteristics of 38 biological clones from 5 European and 7 African HIV-1 isolates belonging to 3 different subtypes (subtype A, B, and D) was investigated. Seventeen of 19 clones displaying a syncytium-inducing (SI) capacity had a positively charged amino acid located at position 11 and/or 25 in the V3 loop sequence. All 19 non-syncytium-inducing (NSI) virus clones lacked such a positive charge at the same positions (p < 0.001). The mean of net charge in the overall V3 loop sequences of the SI clones was higher than that of the NSI clones (p < 0.001). Within the same strains, the SI clones replicated faster/higher than the NSI clones in peripheral blood mononuclear cells (p < 0.01), but not in CD4+ T cell cultures (p > 0.1). All SI clones but only 5 of 19 NSI clones could replicate in human continuous T cell and monocytic cell lines (p < 0.001). A higher number of positively charged amino acid substitutions was found among the subtype D SI clones. Only one of eight autologous sera tested had the ability to neutralize the contemporaneously isolated NSI clones, but not the SI clones. This study indicates that the V3 loop amino acid sequences of HIV-1 biological clones from different origins belonging to different genetic subtypes are clearly correlated with viral syncytium-inducing capacity, cell tropism, and replication rate.

Entities:  

Mesh:

Year:  1995        PMID: 7742038     DOI: 10.1089/aid.1995.11.239

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

1.  Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.

Authors:  A Singh; R G Collman
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Transcriptome analysis of monocyte-HIV interactions.

Authors:  Rafael Van den Bergh; Eric Florence; Erika Vlieghe; Tom Boonefaes; Johan Grooten; Erica Houthuys; Huyen Thi Thanh Tran; Youssef Gali; Patrick De Baetselier; Guido Vanham; Geert Raes
Journal:  Retrovirology       Date:  2010-06-14       Impact factor: 4.602

3.  Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

Authors:  L H Ping; J A Nelson; I F Hoffman; J Schock; S L Lamers; M Goodman; P Vernazza; P Kazembe; M Maida; D Zimba; M M Goodenow; J J Eron; S A Fiscus; M S Cohen; R Swanstrom
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.

Authors:  R F Speck; K Wehrly; E J Platt; R E Atchison; I F Charo; D Kabat; B Chesebro; M A Goldsmith
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda.

Authors:  Ned Sacktor; Noeline Nakasujja; Richard L Skolasky; Mona Rezapour; Kevin Robertson; Seggane Musisi; Elly Katabira; Allan Ronald; David B Clifford; Oliver Laeyendecker; Thomas C Quinn
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

6.  Adaptive mutations in a human immunodeficiency virus type 1 envelope protein with a truncated V3 loop restore function by improving interactions with CD4.

Authors:  Caroline Agrawal-Gamse; Fang-Hua Lee; Beth Haggarty; Andrea P O Jordan; Yanjie Yi; Benhur Lee; Ronald G Collman; James A Hoxie; Robert W Doms; Meg M Laakso
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

7.  Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.

Authors:  J P Moore; Y Cao; J Leu; L Qin; B Korber; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.

Authors:  Nathalie Boutonnet; Wouter Janssens; Carlo Boutton; Jean-Luc Verschelde; Leo Heyndrickx; Els Beirnaert; Guido van der Groen; Ignace Lasters
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 9.  Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

10.  Genotypic prediction of HIV-1 subtype D tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Marie-Laure Chaix; Michelle Cazabat; Stéphanie Encinas; Patrick Bruel; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  Retrovirology       Date:  2011-07-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.